The efficacy of adjuvant chemotherapy for T1N0M0 triple-negative breast cancer (TNBC) has not been clearly elucidated. Thus, we aimed to evaluate the efficacy of adjuvant chemotherapy for patients with T1a鈥揷N0M0 TNBC. PATIENTS AND METHODS. Patients newly diagnosed with TNBC between 2011 and ...
European Journal of Medical Research (2024) 29:599 https://doi.org/10.1186/s40001-024-02139-1 European Journal of Medical Research RESEARCH Open Access Does T1c–2N0–1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy? Ruiliang Chen1†, Yushuai Yu2†...
Genetic instability promotes the acquisition of chromosomal imbalances in T1b and T1c breast adenocarcinomas. Harald Blegen,B. Michael Ghadimi,Annukka Jauho,... - 《Analytical Cellular Pathology the Journal of the European Society for Analytical Cellular Pathology》 ...
e12606#Background:ACOSOG Z0011 trial showed that in early cT1-2N0 breast cancer patients with 1-2 positive lymph nodes in sentinel lymph node biopsy (SLNB)... X Li,Q Liu,Y Li - 《Journal of Clinical Oncology》 被引量: 0发表: 2024年 加载更多来源...
Quadrantectomy and axillary dissection vs quadrantectomy alone as surgical treatment for T1a,b,c N0 breast cancer. Early results of Milan V: a randomised clinical trialElectrochemistrysemiconductor nanocrystalsoligothiophenessurface functionalization
Breast cancerSurvivalChemotherapyAlthough neoadjuvant chemotherapy (NCT) is a standard approach for operable triple negative breast cancer (TNBC), the potential risks brought by it should also be noticed. Is the expanding indication of NCT to T1cN0M0 population appropriate? We conducted an ...
Ongoing discussions persist concerning the precedence of neoadjuvant therapy (NAT) relative to adjuvant therapy (AT) for patients with T1c, node-negative, triple-negative breast cancer (TNBC), and pertinent guidelines for these individuals are absent. Women diagnosed with T1cN0M0-stage TNBC who ...
PURPOSE: Our previous study demonstrated breast-conserving surgery with radiation therapy (BCT) to be at least equivalent to mastectomy in T1-2N0-1 breast cancer. Yet, 10-year survival rates after BCT and mastectomy with radiation therapy (MAST) in T1-2N2 breast cancer specifically have not be...
Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 ... et al.Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis,invasiveness,or both,in clinical...
CancerDiseasesMedical researchOncologyMetaplastic breast carcinoma (MpBC) is considered a highly aggressive disease, the outcome of chemotherapy on small lesions (T1abcN0M0) MpBC patients remain unclear. We identified 890 female MpBC patients in the Surveillance, Epidemiology, and End Results (SEER) ...